Eyestem receives CDSCO approval to initiate Phase 2 randomised, controlled human...
Eyestem Research has secured approval from India's CDSCO to begin Phase 2 clinical trials for its Eyecyte-RPE cell thera...
Eyestem Research has secured approval from India's CDSCO to begin Phase 2 clinical trials for its Eyecyte-RPE cell thera...
Indian pharma leaders are urging the government for increased research and development incentives in the upcoming Union ...
US health insurance stocks today: Stocks of major US health insurance companies like UnitedHealth, Humana, and CVS fell ...
Neurosurgeon Dr. Brian Hoeflinger stresses sleep's vital role in brain health and performance, not as a luxury but a nec...
Medical inflation in India is soaring, making health insurance unaffordable and leading to higher out-of-pocket expenses...
A Reddit user conducted an experiment applying for the same job twice with different résumés. One application, focus...
Influencer Sammy Yahood faces a visa ban from Australia. He was scheduled to speak at events for Jewish audiences. Yahoo...
The Supreme Court has postponed a hearing on a law regulating school fees in Delhi. The next hearing is scheduled for Fe...
France's National Assembly has backed legislation to ban children under 15 from social media, mirroring Australia's rece...
NATO Secretary General Mark Rutte said on Monday (January 26) he and U.S President Trump had agreed upon two "workstream...